Qixue Song

605 citations
16 papers · 398 indexed · h-index 10
Topics
Angiogenesis and VEGF in Cancer (4 papers)TGF-β signaling in diseases (2 papers)Cardiac Fibrosis and Remodeling (2 papers)

In The Last Decade

Qixue Song

15 papers receiving 393 citations

Peers

Qixue Song
Comparison fields: 5 of 70
  • Molecular Biology 207
  • Cancer Research 91
  • Cardiology and Cardiovascular Medicine 81
  • Surgery 60
  • Epidemiology 43
Replace Kathryn M. Citrin with:
Kathryn M. Citrin United States
Hu Sheng Qian United States
Michitaka Tsuzuki Japan
Yuko Oyama Japan
Shiyue Xu China
Yangguang Yin China
Kristen Leslie United States
Mar Orriols Spain
Tania Tsatralis Australia
Qixue Song relative to Kathryn M. Citrin United States Kathryn M. Citrin's profile →
Citations per field
00.5×2.8×
Kathryn M. Citrin · 1×
Citations per year

Countries citing papers authored by Qixue Song

Since Specialization
Citations

This map shows the geographic impact of Qixue Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qixue Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qixue Song more than expected).

Fields of papers citing papers by Qixue Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qixue Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qixue Song. The network helps show where Qixue Song may publish in the future.

Co-authorship network of co-authors of Qixue Song

This figure shows the co-authorship network connecting the top 25 collaborators of Qixue Song. A scholar is included among the top collaborators of Qixue Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qixue Song. Qixue Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 0
2 13
3 1
4 1
5 3
6 10
7 56
8 1
9 25
10 94
11 22
12 42
13 38
14 74
15 15
16
Nepafenac Metabolite, Amfenac, Inhibits VEGF Induced Phosphorylation of ERK in Human Retinal Microvascular Endothelial Cells
3

About Qixue Song

Qixue Song is a scholar working on Cancer Research, Gastroenterology and Biochemistry, having authored 16 papers that have together received 398 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), TGF-β signaling in diseases (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). The work is most often cited by research in Cancer Research (91 citations), Cardiology and Cardiovascular Medicine (81 citations) and Molecular Biology (207 citations). Qixue Song has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yufeng Yao, Changqing Hu, Qing K. Wang, Qiuyun Chen, Xingwen Da, Chengqi Xu, Zhenkun Hu, Yubing Yu, Yubin Yu and Ian M. Clark. Their work appears in journals such as Journal of Biological Chemistry, Diabetes and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026